{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:20:34Z","timestamp":1764174034524},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":427,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Unconditional Grant by Galderma France"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1111\/bjd.12838","type":"journal-article","created":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T07:19:00Z","timestamp":1389856740000},"page":"130-136","source":"Crossref","is-referenced-by-count":17,"title":["Antihypertensive drugs and the risk of incident rosacea"],"prefix":"10.1093","volume":"171","author":[{"given":"J.","family":"Spoendlin","sequence":"first","affiliation":[{"name":"Division of Clinical Pharmacy and Epidemiology; Department of Pharmaceutical Sciences; University Hospital Basel; Basel Switzerland"},{"name":"Basel Pharmacoepidemiology Unit; Hospital Pharmacy; University Hospital Basel; Basel Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Voegel","sequence":"additional","affiliation":[{"name":"Galderma Research & Development; Sophia Antipolis France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.S.","family":"Jick","sequence":"additional","affiliation":[{"name":"Boston Collaborative Drug Surveillance Program; Boston University; Lexington MA U.S.A"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.R.","family":"Meier","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy and Epidemiology; Department of Pharmaceutical Sciences; University Hospital Basel; Basel Switzerland"},{"name":"Basel Pharmacoepidemiology Unit; Hospital Pharmacy; University Hospital Basel; Basel Switzerland"},{"name":"Boston Collaborative Drug Surveillance Program; Boston University; Lexington MA U.S.A"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,7,6]]},"reference":[{"key":"10.1111\/bjd.12838-BIB0001|bjd12838-cit-0001","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12838-BIB0002|bjd12838-cit-0002","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/jidsymp.2011.6","article-title":"Neurovascular and neuroimmune aspects in the pathophysiology of rosacea","volume":"15","author":"Schwab","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1111\/bjd.12838-BIB0003|bjd12838-cit-0003","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/jidsymp.2011.7","article-title":"Clinical, cellular, and molecular aspects in the pathophysiology of rosacea","volume":"15","author":"Steinhoff","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1111\/bjd.12838-BIB0004|bjd12838-cit-0004","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/jidsymp.2011.8","article-title":"Neurovascular aspects of skin neurogenic inflammation","volume":"15","author":"Aubdool","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1111\/bjd.12838-BIB0005|bjd12838-cit-0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdermsci.2009.04.007","article-title":"The molecular pathology of rosacea","volume":"55","author":"Yamasaki","year":"2009","journal-title":"J Dermatol Sci"},{"key":"10.1111\/bjd.12838-BIB0006|bjd12838-cit-0006","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMcp042829","article-title":"Clinical practice. Rosacea","volume":"352","author":"Powell","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.12838-BIB0007|bjd12838-cit-0007","first-page":"38","article-title":"Rosacea: a review","volume":"34","author":"Culp","year":"2009","journal-title":"P T"},{"key":"10.1111\/bjd.12838-BIB0008|bjd12838-cit-0008","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1468-3083.2010.03751.x","article-title":"Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group","volume":"25","author":"Elewski","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12838-BIB0009|bjd12838-cit-0009","first-page":"97","article-title":"Standard management options for rosacea, part 2: options according to subtype","volume":"84","author":"Odom","year":"2009","journal-title":"Cutis"},{"key":"10.1111\/bjd.12838-BIB0010|bjd12838-cit-0010","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jaad.2005.07.021","article-title":"Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol","volume":"53","author":"Craige","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12838-BIB0011|bjd12838-cit-0011","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaad.2012.04.017","article-title":"Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a nonselective beta-adrenergic blocker","volume":"67","author":"Hsu","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12838-BIB0012|bjd12838-cit-0012","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1001\/archdermatol.2011.204","article-title":"Carvedilol for the treatment of refractory facial flushing and persistent erythema of rosacea","volume":"147","author":"Hsu","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12838-BIB0013|bjd12838-cit-0013","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0190-9622(89)70022-0","article-title":"Effect of nadolol on flushing reactions in rosacea","volume":"20","author":"Wilkin","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12838-BIB0014|bjd12838-cit-0014","unstructured":"National Institute for Health and Care Excellence Clinical Knowledge Summaries http:\/\/cks.nice.org.uk\/rosacea#!scenariorecommendation"},{"key":"10.1111\/bjd.12838-BIB0015|bjd12838-cit-0015","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/hr.2011.32","article-title":"Worsening of rosacea in patients treated with dihydropyridine calcium channel blockers: a clinical observation","volume":"34","author":"Natale","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1111\/bjd.12838-BIB0016|bjd12838-cit-0016","volume-title":"Hypertension - Clinical Management of Primary Hypertension in Adults","author":"National Institute for Health and Care Excellence","year":"2011"},{"key":"10.1111\/bjd.12838-BIB0017|bjd12838-cit-0017","volume-title":"MI: Secondary Prevention","author":"National Institute for Health and Care Excellence","year":"2007"},{"key":"10.1111\/bjd.12838-BIB0018|bjd12838-cit-0018","volume-title":"Chronic Heart Failure - National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care","author":"National Institute for Health and Care Excellence","year":"2010"},{"key":"10.1111\/bjd.12838-BIB0019|bjd12838-cit-0019","volume-title":"Stroke - National Clinical Guideline for Diagnosis and Initial Management of Acute Stroke and Transient Ischaemic Attack","author":"National Institute for Health and Care Excellence","year":"2008"},{"key":"10.1111\/bjd.12838-BIB0020|bjd12838-cit-0020","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.3399\/bjgp10X483562","article-title":"Validity of diagnostic coding within the General Practice Research Database: a systematic review","volume":"60","author":"Khan","year":"2010","journal-title":"Br J Gen Pract"},{"key":"10.1111\/bjd.12838-BIB0021|bjd12838-cit-0021","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(97)04248-7","article-title":"The UK general practice research database","volume":"350","author":"Walley","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/bjd.12838-BIB0022|bjd12838-cit-0022","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2165\/00002018-200427120-00004","article-title":"The general practice research database: role in pharmacovigilance","volume":"27","author":"Wood","year":"2004","journal-title":"Drug Saf"},{"key":"10.1111\/bjd.12838-BIB0023|bjd12838-cit-0023","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2133.2012.11037.x","article-title":"A study on the epidemiology of rosacea in the U.K","volume":"167","author":"Spoendlin","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12838-BIB0024|bjd12838-cit-0024","unstructured":"WHO Collaborating Centre for Drug Statistics and Methodology http:\/\/www.whocc.no\/atc_ddd_index\/?code=C08"},{"key":"10.1111\/bjd.12838-BIB0025|bjd12838-cit-0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pcad.2004.04.006","article-title":"Calcium antagonists","volume":"47","author":"Grossman","year":"2004","journal-title":"Prog Cardiovas Dis"},{"key":"10.1111\/bjd.12838-BIB0026|bjd12838-cit-0027","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1468-3083.2000.00144.x","article-title":"What's going on in rosacea?","volume":"14","author":"Powell","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12838-BIB0027|bjd12838-cit-0028","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1751-7176.2011.00515.x","article-title":"Beta-adrenergic blockers","volume":"13","author":"Frishman","year":"2011","journal-title":"J Clin Hyperten"},{"key":"10.1111\/bjd.12838-BIB0028|bjd12838-cit-0029","unstructured":"British National Formulary http:\/\/www.medicinescomplete.com\/mc\/bnf\/current\/PHP944-propranolol-hydrochloride.htm?q=propranolol&t=search&ss=text&p=1#_hit"},{"issue":"6 Suppl. 1","key":"10.1111\/bjd.12838-BIB0029|bjd12838-cit-0030","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.jaad.2013.04.041","article-title":"Emerging therapies in rosacea","volume":"69","author":"Layton","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12838-BIB0030|bjd12838-cit-0031","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2340\/00015555-0716","article-title":"Subjective disease perception and symptoms of depression in relation to healthcare-seeking behaviour in patients with rosacea","volume":"89","author":"Abram","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.12838-BIB0031|bjd12838-cit-0032","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2133.2012.10906.x","article-title":"The South-East Scotland Dermatology Workload Study: 30\u00a0years. analysis","volume":"167","author":"Holme","year":"2012","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12838","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12838\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:08:30Z","timestamp":1676383710000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/171\/1\/130\/6615681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12838","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}